Accessibility navigation

Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis

Langran, T., Nanda, N., Bataveljic, A. and Gonzalez-Durio, J. (2017) Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis. BMJ Open, 7 (3). e013451. ISSN 2044-6055

Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.


It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1136/bmjopen-2016-013451


Abstract Objective Describe and assess the impact of a pharmacist-led patient review programme on the management and control of type 2 diabetes (T2D). Design Uncontrolled prospective cohort study with before and after intervention data collection. Setting General practices within NHS Slough Clinical Commissioning Group (CCG). Participants 5910 patients with T2D. Interventions Pharmacists reviewed 5910 patients and worked with general practice teams to schedule any of the 9 key care processes recommended by the National Institute for Health and Care Excellence (NICE) that the patients were lacking, to optimise medication and to make other interventions such as providing lifestyle advice. Main outcome measures The proportion of patients receiving the NICE-recommended 9 key care processes and proportion of patients whose glycated haemoglobin (HbA1c), blood pressure (BP) or total cholesterol (TC) readings were over target before and after the intervention period. Results The proportion of patients receiving all of the NICE-recommended 9 key care processes increased from 46% at project outset in April 2013 to 58% on completion in April 2014 and the percentage of patients achieving HbA1c, BP and TC targets all increased (65% to 70%, 70% to 76%, 78% to 82%, respectively). Quality Outcomes Framework (QOF) data for Slough CCG showed the percentage of diabetic patients achieving target HbA1c, BP and TC readings increased from April 2013 to April 2014, but then diminished in the year after project completion. Conclusions The pharmacist-led review increased the number of key care processes administered and improved diabetic control during the year of programme delivery. The improvement abated during the year after, suggesting that such programmes should be ongoing rather than fixed term. The programme combined the strategic drive and project facilitation skills of Slough CCG, the general practice teams' knowledge of their patients and the clinical and information technology skills of an experienced pharmacist team.

Item Type:Article
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmacy Practice Research Group
ID Code:69510
Publisher:BMJ Group


Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation